Marianne De Backer Salary and Compensation - Vir Biotechnology, Inc. CEO Pay 2025

In fiscal year 2025, Marianne De Backer, M.Sc., Ph.D., MBA President, Chief Executive Officer and Director of Vir Biotechnology, Inc. (VIR), received total compensation of $7.8 million.

Marianne De Backer's compensation breakdown includes: base salary of $950K, stock awards valued at $2.3 million, option awards of $3.5 million, non-equity incentive compensation of $1.0 million, and other compensation of $77K.

Compared to fiscal year 2024, Marianne De Backer's total compensation decreased 15% from $9.3 million to $7.8 million.

Vir Biotechnology, Inc. (VIR) Executive Pay 2025

Vir Biotechnology, Inc.'s top 4 named executive officers received combined total compensation of $13.8 million in fiscal year 2025.

The named executive officers disclosed in Vir Biotechnology, Inc.'s 2025 proxy statement are:Marianne De Backer (M.Sc., Ph.D., MBA President, Chief Executive Officer and Director) with total compensation of $7.8 million, Mark Eisner (M.D., M.P.H .(6) Executive Vice President and Chief Medical Officer) with total compensation of $2.4 million, Jason O’Byrne (MBA Executive Vice President and Chief Financial Officer) with total compensation of $2.0 million, and Vanina De Verneuil (J.D. Executive Vice President, General Counsel and Corporate Secretary) with total compensation of $1.7 million.